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Neocentromeres: New Insights into Centromere Structure,
Disease Development, and Karyotype Evolution
Owen J. Marshall,1,2,3 Anderly C. Chueh,1,2,3 Lee H. Wong,1,2 and K.H. Andy Choo1,2,*Since the discovery of the ﬁrst human neocentromere in 1993,
these spontaneous, ectopic centromeres have been shown to be
an astonishing example of epigenetic change within the genome.
Recent research has focused on the role of neocentromeres in
evolution and speciation, as well as in disease development and
the understanding of the organization and epigenetic mainte-
nance of the centromere. Here, we review recent progress in these
areas of research and the signiﬁcant insights gained.
In all eukaryotic organisms, the centromere is the funda-
mental structure that controls the segregation of genetic
material at meiosis and mitosis. With a few exceptions
(such as the point centromeres of the budding yeast
Saccharomyces cerevisiae and the centromeres of at least
one species of Trypanosome1), almost all centromeres are
characterized by an accumulation of repetitive satellite
DNA, often present in higher-order arrays.
In general, such centromeric repeats are speciﬁc to the
species and indicate some form of sequence sharing
between centromeres. In primates, the repeat motif has
been termed alpha-satellite (or alphoid) DNA,2 and in
humans, a consensus sequence exists between chromo-
somes.3 Understandably, therefore, the concept of a close
relationship between DNA sequence and centromere
formation was compelling in early centromere research.
All this changed, however, with the discovery in 1993 of
an ectopic centromere, or neocentromere, formed on
a marker chromosome without any alpha-satellite DNA.4
The marker chromosome in question, designated mar-
del(10), had formed from a de novo rearrangement of
chromosome 10 into a ring chromosome containing the
normal centromere, and a linear chromosome completely
lacking in centromeric alpha-satellite DNA. Nevertheless,
this acentric maker chromosome had been rescued by
the spontaneous formation of a new centromere at the
cytogenetic band 10q25—a euchromatic region of the
chromosome arm that had not undergone any rearrange-
ment or sequence change.5,6 This was the discovery of
a striking epigenetic phenomenon: the ability of a structure
as complex as a centromere to spontaneously form at
a seemingly random genomic location was unprecedented.
Such neocentromeres are quite different from the ‘‘clas-
sical’’ plant neocentromeres ﬁrst described by Rhoades
and Vilkomerson,7 and they lack fundamental centromere
proteins and interact with microtubules in a very different1Chromosome and Chromatin Research, Murdoch Children’s Research Institu
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Hiatt8). In contrast, human neocentromeres have been
shown to bind all known essential centromere proteins
and behave identically in mitosis and meiosis to their
satellite-DNA-based counterparts.
Since the initial discovery in 1993, over ninety cases of
neocentromere formation in humans have been described
in the literature. These cases, together with research from
other organisms, have led not only to a greater understand-
ing of the processes of neocentromere formation itself, but
also to important insights into the structure and function
of all centromeres and the major role the neocentromere
phenomenon plays in karyotype evolution and speciation.Constitutional Human Neocentromeres
Most of the initial information on neocentromeres has
stemmed from human clinical data gathered through
cytogenetic screening (Table 1, Figure 1A). In general,
neocentric marker chromosomes form when an acentric
chromosomal fragment is rescued via the formation of
a neocentromere, and these marker chromosomes result
from two main classes of chromosomal rearrangement.
These are either an inverted duplication (inv dup) of the
distal part of a chromosome arm resulting in an unbal-
anced karyotype (class I), or a balanced chromosomal rear-
rangement into linear and circular marker chromosomes
after an interstitial deletion (class II) (Figure 2).
Of the two main forms of neocentric chromosomal rear-
rangements, class I marker chromosomes are by far the
most commonly reported.These invertedduplicatedmarker
chromosomes represent 74% (67 out of 90 classiﬁed cases,
Table 1) of neocentric chromosomes. Theymight be present
as either supernumerary inv dup chromosomes (thus mak-
ing the individual tetrasomic for the region of duplication)
or with a deleted chromosome complementary for the
region of duplication (thus leading to partial trisomy).
Precisely how these markers form is unknown, but from
studies of parental DNAmarkers, it is clear that they might
form at either meiosis or mitosis,9,10 and several mecha-
nisms for their formation have been proposed11 (Figure 3).
One clear mechanism involves chromatid breakage at
mitosis, leading to an acentric chromosomal fragment
that might subsequently segregate with either an intact
chromatid or with the complementary broken chromatidte, Parkville, VIC 3052, Australia; 2Department of Paediatrics, University of
Genetics. All rights reserved.
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Table 1. Ninety-Three Constitutional Neocentromere Cases
Chromosome and
Neocentromere Site Rearrangement Karyotype
Mosaicism (Percent Abnormal Cells)
ReferenceFibroblasts Lymphoblasts
1:
1p32-p36.1 Interstitial deletion (paracentric) Balanced 97 100 Slater et al.106
1q21-q22 Supernumerary ring Trisomy Constantinou et al.107 (case 1)
1q23-q32 Interstitial deletion (paracentric) Balanced 85 Higgins et al.108
1q32-qter Deletion þ inv dup Trisomy 100 Kucerova et al.109
1q43-q44 Supernumerary ring Trisomy 70 50 Spiegel et al.110 (case 1)
2:
2p11-p21 Interstitial deletion (paracentric) Balanced 100 Petit and Fryns111
2q35-q36 Supernumerary ring Trisomy 28 Pietrzak et al.112
3:
3p23 Interstitial deletion (pericentric) Balanced 100 100 Maraschio et al.113
3q21.2-qter Supernumerary inv dup Tetrasomy 0 87 Gimelli et al.114 (case 3)
3q24 None Balanced (Ventura et al.71 (case 2)
3q26.1 Interstitial deletion (pericentric) Balanced 100 100 Wandall et al.;14
Ventura et al.71 (case 1)
3q26-qter Supernumerary inv dup Tetrasomy 100 Batanian et al.115
3q26.2-qter Supernumerary inv dup Tetrasomy 2 87 Teshima et al.116 (case 2)
3q26.2-qter Supernumerary inv dup Tetrasomy 57 Cockwell et al.117
3q26.2-qter Supernumerary inv dup Tetrasomy Yu et al.118
3q26.2-qter Supernumerary inv dup Tetrasomy Sullivan et al.119
3q27 Deletion þ inv dup Trisomy 100 Papenhausen et al.120
3q27.1-qter Supernumerary inv dup Tetrasomy 30 6 Portnoi et al.121
3q27.2-qter Supernumerary inv dup Tetrasomy 71 Teshima et al.116 (case 1)
3q28-qter Supernumerary inv dup Tetrasomy 100 Barbi et al.122
3q27.3 Supernumerary inv dup Tetrasomy 87 Gimelli et al.123
4:
4q21 Interstitial deletion (paracentric) Balanced 75 Grimbacher et al.124
4q21.2 Interstitial deletion (pericentric) Balanced 100 Warburton et al.13
4q21.3 None Balanced 100 Amor et al.92
5:
5p14-p15.1 Supernumerary inv dup Tetrasomy 19 Fritz et al.125
6:
6q16.2-q22.2 Interstitial deletion (paracentric) Balanced 100 Qin et al.126
6q26 Supernumerary inv dup Tetrasomy 60 Sala et al.127
8:
8p22-pter Supernumerary inv dup Trisomy 50 18 de Pater et al.128
8p23-pter Supernumerary inv dup Tetrasomy 21 28 Herry et al.129 (case 2)
8p23.1-pter Supernumerary inv dup Tetrasomy 100 Ohashi et al.130
8p23.1-pter Supernumerary inv dup Tetrasomy 25 Neumann et al.131
8p23.2 Supernumerary inv dup Tetrasomy 23–46 Voullaire et al.11 (case 1)
8p23.2 Supernumerary inv dup Tetrasomy 53–60 Voullaire et al.11 (case 2)
8p distal - pter Supernumerary inv dup Tetrasomy 90 100 Velinov et al.132
8q23-qter Supernumerary inv dup Tetrasomy 75 Sulcova et al.133
8q23.3-qter Supernumerary inv dup Tetrasomy 75 Reddy et al.134
9:
9p23 Supernumerary inv dup Tetrasomy 100 Depinet et al.9 (case 5);
Satinover et al.135 (case 2)
9p23 Deletion þ inv dup Trisomy 100 Depinet et al.9 (case 7); Vance
et al.;136 Satinover et al.135 (case 1)
10:
10p14-pter Supernumerary inv dup Tetrasomy 100 Levy et al.137
10q11-q23 Interstitial deletion (paracentric) Balanced 62 80 Depinet et al.9 (case 8)
10q25.2 Interstitial deletion (pericentric) Balanced 100 100 Voullaire et al.;4 Lo et al.4
11:
11p11.12-11.2 Interstitial deletion (paracentric) Balanced 76 Chuang et al.15
11q22-qter Deletion þ inv dup Trisomy 100 100 Depinet et al.9 (case 6)
12:
12p12.3-pter Supernumerary inv dup Tetrasomy 50–57 Dufke et al.138
12p13.31-pter Supernumerary inv dup Tetrasomy 100 Vermeesch et al.139
13:
13q21 Supernumerary inv dup Tetrasomy 49 Warburton et al.99 (case C)
13q21 Deletion þ inv dup Trisomy 100 100 Morrissette et al.100
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Table 1. Continued
Chromosome and
Neocentromere Site Rearrangement Karyotype
Mosaicism (Percent Abnormal Cells)
ReferenceFibroblasts Lymphoblasts
13q21 Supernumerary inv dup Tetrasomy 14 20 Li et al.101 (case 2)




Balanced 100 Knegt et al.;16 Cardone et al.34
13q31 Supernumerary inv dup Tetrasomy 60 Warburton et al.99 (case E)
13q31 Supernumerary inv dup Tetrasomy 13 13 Barwell et al.102
13q31-q32 Interstitial deletion
(paracentric)
Balanced 50–70 Amor et al.103
13q31.3 Supernumerary inv dup Tetrasomy 11 Tonnies et al.104
13q32 Supernumerary inv dup Tetrasomy 98 8 Depinet et al.;9 Warburton
et al.99 (case F)
13q32 Supernumerary inv dup Tetrasomy 100 100 Warburton et al.99 (case G)
13q32 Supernumerary inv dup Tetrasomy 74 25 Warburton et al.99 (Case H)
13q32 Supernumerary inv dup Tetrasomy 56 Li et al.101 (case 1); Alonso et al.33
13q32.1 Deletion þ inv dup Trisomy 100 Rivera et al.;140 Warburton et al.99
(case B); Alonso et al.33
13q33.1 Supernumerary inv dup 3 2 Hexasomy 12–26 Li et al.101 (case 3); Alonso et al.33
13q33.1 Supernumerary inv dup Tetrasomy 88 Warburton et al.99 (case D);
Alonso et al.33
14:
14q32.1-qter Deletion þ inv dup Trisomy 100 Magnani et al.;141 Sacchi et al.142
15:
15 ? ? 100 Li et al.143 (case 11)
15q22 ? ? Constantinou et al.107 (case 2)
15q24 Supernumerary inv dup Tetrasomy 80 Blennow et al.144 (case B)
15q24-qter Supernumerary inv dup Tetrasomy 66 50 Spiegel et al.110 (case 2)
15q24.1 Supernumerary inv dup Tetrasomy 70 11 Blennow et al.144 (case A);
Ventura et al.10 (case 1)
15q24.1-qter Supernumerary inv dup Tetrasomy Tonnies et al.145
15q25 Supernumerary inv dup Tetrasomy 80 Huang et al.146
15q25-qter Supernumerary inv dup Tetrasomy 79 Van den Enden et al.147
15q25-qter Supernumerary inv dup Tetrasomy 100 Huang et al.148
15q25.2 Supernumerary inv dup Tetrasomy Ventura et al.10 (case 2)
15q25.3-qter Supernumerary inv dup Tetrasomy 82 Depinet et al.9 (case 1)
15q25.3-qter Supernumerary inv dup Tetrasomy 74 Depinet et al.9 (case 2)
15q25.3-qter Supernumerary inv dup Tetrasomy 95 Hu et al.149
15q25.3-qter Supernumerary inv dup Tetrasomy 68 Chen et al.150
15q26.1 Supernumerary inv dup Tetrasomy 50–100 18 Rowe et al.151
15q26.1-qter Supernumerary inv dup Tetrasomy 86 Depinet et al.9 (case 3)
15q26.1-qter Supernumerary inv dup Tetrasomy 70 Mahjoubi et al.152
16:
16p Deletion þ iso(16q) Trisomy 16q 100 Tabet et al.153
17:
17q22-q23 Deletion þ inv dup Trisomy 100 Ravnan et al.154
18:
18 ? ? 64 Rauch et al.155 (case 4)
20:
20p12.2 Deletion þ inv dup Trisomy 100 100 Lo et al.32; Voullaire et al.156
21:
21q21.1-qter Deletion þ inv dup Trisomy and deletion 21 100 Barbi et al.157
X:
Xq12 Deletion þ asymmetric inv dup Trisomy and deletion X 82 Kaiser-Rogers et al.158
Xp22.31-pter Supernumerary inv dup Tetrasomy 100 Yu et al.159
Y:
Distal Yp Interstitial deletion? Deletion Y 15 15 Conde et al.160
Yq11.2 None (or inversion?) Balanced? Mosaic Rivera et al.89
Yq11.2 Deletion þ inv dup Disomy and deletion Y 70 Floridia et al.161
Yq11.2 Deletion þ inv dup Disomy and deletion Y 70 Warburton et al.162
Yq11.2 Deletion þ inv dup Disomy and deletion Y 100 Assumpc¸a˜o et al.163
Yq12 Supernumerary Y Disomy 5 Bukvic et al.90
Yq12 None Balanced 94 100 Tyler-Smith et al.91
The American Journal of Human Genetics 82, 261–282, February 2008 263
Figure 1. Constitutional Neocentromeres
(A) Sites of constitutive neocentromere formation in the human genome. The known locations of neocentromeres are represented by bars
aligned against the chromosome ideograms; black bars represent neocentromere formation on class I marker chromosomes, red bars
represent neocentromere formation on class II marker chromosomes, green bars represent sites of centromere repositioning, and gray
bars represent unknown chromosomal rearrangements. Adapted from Amor and Choo.75
(B) Neocentromere hotspots on 13q. Sites of neocentromere formation are shown in yellow within the length of the marker chromosomes,
with markers grouped by neocentromere formation within cytogenetic bands. All reported neocentromere cases from chromosome 13 are
illustrated: a–h are as described by Warburton et al;99 i, Morrissette et al.;100 j, Knegt et al.;16 k–m are cases 1–3, respectively, as de-
scribed by Li et al.;101 n, Barwell et al.;102 o, Amor et al.;103 and p, Tonnies et al.104 Additional mapping data of a and j are from
Cardone et al.34 and b, d, and g from Alonso et al.33 All marker chromosomes are inverted duplications (for the sake of simplicity, the
inversion is not illustrated for these chromosomes), with the exception of two ring chromosomes designated ‘‘R.’’(Figure 3A). If the fragment segregates with an intact chro-
matid, partial tetrasomy will be the result. However, if the
fragment segregates with the complementary broken chro-
matid, the broken chromatid might be saved through telo-
mere restitution and the end result is partial trisomy. In
both cases, the inv dup marker forms after cell division
and DNA replication by rejoining the broken, replicated
ends of the acentric fragment. Partial tetrasomy might
also result from a distal U type exchange at meiosis I,
with subsequent neocentromere formation within the
inverted duplication allowing the rescue of the marker
chromosome (Figure 3B). Once the inv dup marker chro-264 The American Journal of Human Genetics 82, 261–282, Februarymosome has been formed, the neocentromere itself can
form at any location, although a signiﬁcant minority of
inv dup markers are approximately metacentric (see Epige-
netic Mechanisms of Neocentromere Formation for a
discussion of the signiﬁcance of this observation). Out of
all class I markers, partial tetrasomy is by far the more fre-
quent occurrence, representing 80% of all cases (51 out of
64 cases, Table 1), which might represent either the extra
contribution of meiotic formation to these marker chro-
mosomes and/or the relative rarity of a brokenmitotic frag-
ment to segregate with its derivative chromosome. One
ﬁnal point to note regarding the formation of inverted2008
Figure 2. Chromosome Rearrange-
ments after Chromatid Breaks That Are
the Common Cause of Neocentromere
Formation in Humans
Single, unreplicated chromatids of a homol-
ogous chromosome pair are depicted; break
points are indicated with arrowheads, and
the neocentromeres colored red. The re-
sulting effect on the karyotype is listed un-
derneath each alternative rearrangement.duplicated markers is the presence of a small region of un-
duplicated genetic material at the duplication and rear-
rangement boundary of at least some marker chromo-
somes, thus giving an ABC::BA structure to the marker10
(and therefore resulting in partial trisomy [in partially tet-
rasomic individuals] or normality [in partially trisomic in-
dividuals] for region C). Although such marker structure is
suggestive of a meiotic recombination event, analysis of
polymorphic markers within two of these chromosomes
has demonstrated that both chromosomes originated dur-
ingmitosis.10 The implications of this structure for the pro-
cess of inv dup marker chromosome formation are thus
unclear.
Inverted duplicated neocentric marker chromosomes are
often present in the individual in mosaic form. This mosa-
icism might be due to the mechanisms of marker chromo-
some formation or some intrinsic mitotic instability of the
resulting neocentromere, but the selective disadvantage of
partial tetrasomy is likely to be a contributing factor in
some tissues. The loss of an inv dup marker chromosome
from a partially tetrasomic cell will result in a balanced
karyotype and is likely to be favored, whereas the loss of
the marker chromosome from a partially trisomic cell will
result in partial monosomy—a situation generally more
deleterious to cell survival. Notably, this is reﬂected in
the clinical data: 82% (42 out of 51 cases, Table 1) of partial
tetrasomy caused by an inv dup marker chromosome were
found to be mosaic for the marker chromosome, compared
to only 15% (2 out of 13 cases, Table 1) of partial trisomy
cases.
The second most common form of neocentric marker
chromosomes are interstitial deletions (13 out of 90 cases;
14%), whereby a chromosome has been rearranged to formThe American Journal of Humana ring chromosome and a linear
marker chromosome, giving rise to
a balanced karyotype (Figure 2). The
neocentromere can form on either
the linear or ring derivative, which-
ever is left acentric from the initial
rearrangement. Precisely how and
when this rearrangement occurs is
unclear—the general assumption is
that this process occurs via the chro-
mosome breaking twice and the
ends rejoining,12,13 although an alter-native explanation would be looping and homologous re-
combination within a sister chromatid during meiosis I.
These balanced chromosomal rearrangements are gener-
ally marked by the stability of the linear chromosome de-
rivative, and some degree of mosaicism with the ring deriv-
ative (as is common with ring chromosomes), regardless of
which fragment contains the neocentromere. The pheno-
type associated with class II rearrangements is thus limited
to the disrupted region of the chromosome at or around
the breakpoints and the slight aneuploidy of the ring
derivative caused through ring behavior. Because such
genotypic changes can be relatively minor, it is possible
that many such rearrangements have not been detected
through clinical screening. Indeed, there are at least three
examples of class II neocentric marker chromosomes being
detected serendipitously in a phenotypically normal indi-
vidual: twice where the rearrangement was ascertained in
the offspring of an individual14,15 and once where an indi-
vidual was only discovered to possess a rearrangement due
to a high proportion of miscarriages.16
Of the remaining ten classiﬁed constitutional neocentro-
mere cases, three were found on supernumerary rings and
two on deleted p arm fragments of chromosomes. The ﬁnal
ﬁve neocentromeres were in fact not present on marker
chromosomes at all, but rather were found on normal chro-
mosomes with the original, alphoid centromere present,
but deactivated. These extraordinary cases of centromere re-
positioning are discussed in greater detail below (see Centro-
mere Repositioning, Karyotype Evolution, and Speciation).
Prevalence of Human Neocentromeres
An important question in understanding neocentromere
formation is how frequent the phenomenon is. ClearGenetics 82, 261–282, February 2008 265
Figure 3. Possible Mechanisms for the Formation of Inverted Duplicated Neocentric Marker Chromosomes
(A) Formation at mitosis. After chromatid breakage, the acentric fragment can segregate in two possible ways. After subsequent repli-
cation, the broken ends of the acentric fragment rejoin to create the inverted duplication. Neocentromere formation can occur at this
stage or after further rounds of cell division. If the neocentric fragment segregates with its sister chromatid, the result is partial tetras-
omy for the duplicated fragment. On the other hand, if the centric fragment of the chromatid segregates with the neocentric fragment,
the broken ends of the centric fragment can be stabilized by telomere restitution, and the result is partial trisomy for the duplicated
fragment.
(B) Formation at meiosis. An acentric inverted duplicated (inv dup) chromosome is formed through anomalous crossing over during
meiosis I and segregates with a normal sister chromatid to yield the gametes depicted. After fertilization, cells will be tetrasomic for
the duplicated region. The inv dup marker might form a neocentromere during meiosis (as shown) or during subsequent rounds of mitotic
division after fertilization.estimation of this frequency is difﬁcult, but an analysis of
the statistics of reported small supernumerarymarker chro-
mosomes (sSMCs) in the literature might give an indica-
tion of the relative frequency of deleterious neocentromere
formation. Such sSMC chromosomes are rearranged small
markers often featuring the short arms of the acrocentric
chromosomes, with the inverted duplications of chromo-
somes that feature neocentromeres also grouped within
this category. An ongoing compilation of published
sSMC cases made available online has cataloged 2480
sSMC cases in the literature, of which 81 feature conﬁrmed
or putative neocentromeres—suggesting that neocentro-
meres represent around 3% of published sSMC cases. Be-
cause the novelty of neocentromere cases prompts a greater
likelihood of publication, this number might be an overes-
timate. However, a study of 241 unpublished sSMC cases in
2005 suggested a similar frequency—the study found only266 The American Journal of Human Genetics 82, 261–282, Februarythree putative occurrences of neocentromere formation,17
suggesting that neocentromeres represent around 1% of
total sSMC cases. Considering that sSMCs are found in
0.043% of live births,18 these numbers give us an estimate
of neocentromere formation on inverted duplicated chro-
mosomes occurring in approximately 0.0005%–0.0014%,
or once in every 70,000–200,000 live births.
However, such an estimate does not give a full picture of
neocentromere formation. These studies do not include
the incidence of balanced rearrangements (class II neocen-
tromere markers), which, owing to the less severe pheno-
type associated with such cases, might be under reported
in the literature. Furthermore, we can gain no clear
idea of the frequency of centromere-repositioning events
(see Centromere Repositioning, Karyotype Evolution,
and Speciation, below) from these statistics because
such rearrangements have only been detected2008
serendipitously—individuals with such rearrangements
show no detrimental phenotype at all. The overall picture,
then, is that neocentromerization is a rare, but by no
means infrequent event.
Cancer
Although neocentromere formation is in general a rare oc-
currence, certain cancers are associated with the formation
of a complex, rearranged chromosome containing a neo-
centromere. These instances are especially interesting
considering the clear somatic nature of neocentromere
formation in these tumors and the suggestion that neocen-
tromeres have formed in order to stabilize complex rear-
ranged acentric chromosomes.
The best characterised link between neocentromeres and
a speciﬁc form of cancer is found in the atypical lipomas
and well-differentiated liposarcomas (ALP-WDLPS) class
of lipomatous tumors. These cancers aremarked by a super-
numerary ring chromosome or large marker chromosome
devoid of alpha-satellite DNA, comprised primarily of am-
pliﬁed 12q14-15 sequences that contain oncogenes19,20
and possessing a neocentromere at the primary constric-
tion.21,22 This is in direct contrast to other liposarcomas,
which contain the same ampliﬁed 12q14-15 sequences
but on chromosomes with alphoid centromeres.21 Thus,
the presence of a marker chromosome with a neocentro-
mere appears to be a deﬁning characteristic of this tumor
class.
With the strong link between an ampliﬁed sequence
and the formation of a neocentromere, it might be ex-
pected that the neocentromere was formed from the am-
pliﬁed DNA. This, however, appears not to be the case.
Although the neocentric marker chromosomes consist
largely of the 12q14-15 region, immuno-ﬂuorescence in
situ hybridization (immuno-FISH) showed the kineto-
chore proteins to be bound to DNA from other regions
present in these chromosomes.21 The formation of these
marker chromosomes might thus be a multistep process,
involving the ampliﬁcation of 12q14-15 and the capture
and/or ampliﬁcation of a different sequence involved in
neocentromere formation.
Precisely why there should be a selective advantage con-
ferred by the formation of a new marker chromosome
complete with a neocentromere, as opposed to the ampli-
ﬁcation of these sequences within an existing chromo-
some, is unclear. Interestingly, though, similar lipomatous
tumors where the region from 12q is ampliﬁed on marker
chromosomes with alphoid centromeres are aggressive,
metastatic tumors, and thus have very different behavior
to the ALP-WDLPS tumors—suggesting a difference be-
tween alphoid centromeres and neocentromeres in this
instance.21 One intriguing possibility would be that these
more aggressive lipomatous tumors are derived from
ALP-WDLPS tumors where the neocentromere has rapidly
evolved into a repetitive, alphoid centromere, in a process
similar to centromere repositioning, described below.
However, whether there is a link between the aggressiveThe Amenature of a tumor and the presence of alpha-satellite at
a marker centromere is at this stage unclear.
Neocentromeres have also been reported in other types
of cancers. The marker chromosomes in one lung carci-
noma patient were found to contain a neocentromere asso-
ciated with an ampliﬁcation of the 9p23-24 region.23 The
fact that neocentromeres have twice been previously re-
ported at 9p23 suggests that ampliﬁcation of this region
might perhaps have facilitated neocentromere formation
and stabilized the marker chromosome. Neocentromeres
have also been described in two acute myeloid leukemia
(AML [MIM 601626]) tumors, although these two cases
involved different chromosome rearrangements. In one
instance, the neocentromere was present on a standard
inverted duplication of 10q,24 and in the other, a complex,
rearranged ring chromosome.20
Although neocentromeres have only been described in
three forms of cancer thus far, it is possible that the fre-
quency of neocentromere formation in cancers is much
higher than the literature suggests, because most cancers
are not subjected to karyotype analysis that would detect
neocentromere formation. There are also the intriguing
reports that two important centromere proteins, CENPA
(MIM 117139) and CENPH (MIM 605607), are overex-
pressed in all colorectal cancer (CRC [MIM 114500]) cell
lines and tissues.25,26 Considering the possible ectopic
kinetochore formation associated with CENPA overex-
pression27 described below (see Epigenetic Mechanisms
of Neocentromere Formation), it is possible that upregula-
tion of centromere proteins that promote neocentromeri-
zation is a common step in the promotion of the genome
rearrangements and abnormalities that lead to cancer. Kar-
yotyping of these cancer cell lines known to overexpress
centromere proteins would provide a clear indication as
to whether a link exists between the two.
Organization of Centromere Proteins
At mitosis, human neocentromeres behave identically to
alphoid centromeres, binding all known centromere pro-
teins (with the exception of the alphoid sequence-speciﬁc
and apparently redundant protein CENPB [MIM
117140]).28,29 The spatial relationships between these
proteins in building the inner centromere is of great im-
portance in the understanding of the structure of the cen-
tromere, and neocentromeres have proved to be a vital
means of examining this problem. A unique research ad-
vantage that neocentromeres provide is their lack of repet-
itive DNA, and this has allowed detailed mapping of the
chromatin-binding domains of centromere proteins—
something that has been difﬁcult to achieve with normal
centromeres.
Centromere Protein CENPA
The fundamental innerkinetochore protein CENPA is the
most extensively mapped protein at neocentromeres.
This protein, a histone H3 (H3F2 [MIM 142780]) paralogue
found only at the nucleosomes of active centromeres,30,31rican Journal of Human Genetics 82, 261–282, February 2008 267
Figure 4. The Size and Distribution of Mapped Protein
Domains at Neocentromeres
(A) Innerkinetochore domain organization at seven neocentro-
meres. The size of the protein-binding domain for each neocentro-
mere is listed. Known protein-coding genes present within these
domains are shown (derived from Ensembl release 44). The discon-
tinuous nature of the mardel(10)35 and BBB36 neocentromeres is
illustrated. Two possibilities of the layout of the BBB neocentro-
mere are provided—see main text for details. The IMS13q CENPC1
and CENPH domains are marked ‘‘? ’’ to represent an uncertainty as
to the size of these domains—the authors of this study suggested
that the lower efficiency of ChIP with CENPC1 and CENPH anti-
bodies might prevent the full extent of these domains from being
detected.36
(B) Scaffold domains, protein binding domains, and genes present
within two mapped neocentromeres. Known protein-coding genes
present within these domains are shown (derived from Ensembl re-
lease 44), with expression data from cell lines derived from Saffery
et al.50 and Wong et al.67 Differentially expressed genes denote two
protein-coding genes found to be activated after neocentromere
formation.67 (Domain positions are derived from BAC data from
Lo et al.,6,32 Alonso et al.,33 Cardone et al.,34 and Saffery et al.50
updated against Ensembl release 44 from the Ensembl project105.)has been mapped to six neocentromeres at 100–200 kb res-
olution level via chromatin immunoprecipitation (ChIP)
and bacterial artiﬁcial chromosome (BAC) DNA array anal-
ysis.6,32–34 From these somewhat low-resolution ChIP and
array mapping experiments, it is clear that some variability
in the size of the CENPA domain exists between neocentro-
meres (Figure 4A), with the extent covered by CENPA rang-
ing from 218 kb to 464 kb.
For two of the neocentromeres, the mardel(10) neocen-
tromere at 10q25 and the BBB neocentromere at 13q33,
CENPA has been mapped at higher resolution with an ar-
ray of polymerase chain reaction (PCR) fragments.35,36
The ﬁrst study to achieve this used PCR fragments with
an average size of 8 kb to map the mardel(10) neocentro-
mere.35 At this resolution, the CENPA domain was shown
to comprise seven separate regions interspersed with his-
tone H3 (Figure 4A). The regions of CENPA binding were
regularly spaced, with an average of 54 kb peak-to-peak dis-
tance (standard deviation: 10 kb). Such a result suggested
a similar organization of centromeric chromatin at the
neocentromere to that found atnormal centromeres,where
interspersed regions of CENPA and H3 binding had previ-
ously been shown by stretched chromatin ﬁber studies.37
Taken together, the data suggested a contiguous unit of
CENPA at the inner kinetochore plate formed by coiling
of the chromatin ﬁber into a series of stacked loops.35,37,38
Evenly spaced clusters within the CENPA domain were
less evident at the smaller BBB neocentromere.36 This
study used PCR fragments around 1 kb in size as the basis
of the array—providing a higher resolution, but with per-
haps a lower signal:noise ratio. The study showed a major
CENPA binding domain 88 kb in size, and a second,
smaller domain of 13 kb. Curiously, the two domains
were separated by a stretch of 157 kb—a distance greater
than the size of the two domains combined. It is there-
fore unlikely that these two domains represent two adja-
cent coils of chromatin, and it is possible that this repre-
sents a malformed neocentromere with CENPA present in
a discontinuous domain across the innerkinetochore
plate. However, considering that the inv dup chromo-
some marker carrying this neocentromere was 100% sta-
ble in cell culture,33 this scenario seems unlikely. Rather,
we would suggest the alternative possibility that this cu-
rious distribution of CENPA represents a small inversion
of 160 kb in the patient and that the CENPA domain
is, in fact, a contiguous unit of 101 kb that merely ap-
pears to be discontinuous when mapped back to the con-
sensus sequence of the human genome (Figure 4A) (see
Epigenetic Mechanisms of Neocentromere Formation be-
low for a further discussion of the possible implications
of this observation.) Within the major CENPA-binding
domain, there was some evidence of regular, localized sig-
nal troughs—suggesting a possible concordance with the
data from the mardel(10) neocentromere, albeit with
much smaller chromatin loops. Nevertheless, some
CENPA binding was shown to be present by real-time
PCR within the trough domains,36 and the implications268 The American Journal of Human Genetics 82, 261–282, February 2008
Figure 5. Fine Structural Localization of CENPA at a Human
Alphoid Centromere and a Neocentromere
A 45-nm-thick section through each chromosome is shown. Chro-
mosomes were sorted by flow cytometry, fixed in acetone, and
labeled with a mouse monoclonal anti-human CENPA primary anti-
body (MBL) and a Ultrasmall gold anti-mouse secondary antibody
(Aurion) before postfixation, embedding, and sectioning. The scale
bar represents 200 nm.of this for the structure of the BBB neocentromere remain
unclear.
One interesting aspect of the multiple neocentromere
mapping results for CENPA is the variability in the size of
the CENPA domain. Does this reﬂect a similar change in
the size of the innerkinetochore plate and the primary con-
striction between neocentromeres? If the physical size of
the kinetochore is variable, this might point to the tran-
sient nature of neocentromeres and perhaps suggest that
such structures only reach maturity upon the subsequent
incorporation of satellite DNA. However, an alternative ex-
planation is also possible. Rather than reﬂecting a variation
in the physical size of the kinetochore, the results might
instead represent a variation in the size of the loops of
the coiled chromatin ﬁber that form the basis of the
CENPA domain (see above). By a variety of methods, the
average loop size in human chromosomes has been esti-
mated to be between 30 and 90 kb.39–42 If the seven peaks
of CENPA binding at the mardel(10) neocentromere repre-
sent an end-to-end distance of six loops (ﬁve full loops and
two half loops), it could be expected that a CENPA-binding
domain made of seven binding peaks could range between
180 and 540 kb. Such a prediction ﬁts well with ﬁve of the
seven mapped neocentromeres but fails to adequately ex-
plain the size of the two smallest and perhaps structurally
more primitive neocentromeres.
Although such mapping data provides a substantial
amount of information regarding the structure of neo-
centromeres, it is important to understand whether neo-
centromeres are truly structurally homologous to alphoid
centromeres. In order to answer this question, the physical
distribution of CENPA has recently been studied at normal
centromeres and at a neocentromere through the use of
high-resolution electron microscopy (EM). Through the
use of ﬂow-cytometry to isolate individual populations of
chromosomes, the distribution of CENPA at themardel(10)
neocentromere could be directly compared to that found at
normal alphoid centromeres (O.J.M., A.T.M., and K.H.A.C.,
unpublished data). The results suggested a surprising simi-
larity in the CENPA-binding-domain size between the two
types of centromeres: In both cases, there was no signiﬁ-
cant difference between the physical size of the CENPA
domain or in the proportion of chromatin occupied by
CENPA relative to the constriction (Figure 5).
In addition to investigation of the physical size of the
CENPA-binding domain, the relative amount of CENPA
present on neocentromeres has been compared to that
found on normal centromeres. Through the use of a cell
line expressing a green ﬂuorescent protein (GFP)-CENPA
fusion protein and the measurement of the relative levels
of ﬂuorescence, two separate neocentromeres on the mar-
del(10) and invdup(20) chromosomes were shown to bind
only one-third the amount of CENPA asmost other human
centromeres.43 With the EM data above, this suggests that
the loading of CENPA at the inner plate is less efﬁcient at
neocentromeres. This suggestion is also supported by re-
cent ultra-high-resolution ChIP at a subnucleosome levelThe Amewith an oligonucleotide DNA array, which has demon-
strated that at one neocentromere, CENPA nucleosomes
are not present in contiguous, uniform blocks, but rather
that individual CENPA-containing nucleosomes are inter-
spersed with canonical H3 nucleosomes.36
Precisely why the incorporation of CENPA at neocentro-
meres should be less efﬁcient, though, is less clear. Interest-
ingly, neocentromeres and the Y chromosome centro-
mere—which also exhibits signiﬁcantly reduced CENPA
binding43—both fail to bind CENPB. Considering that
CENPA has been shown to be strongly associated with al-
pha-satellite sequences containing the CENPB box (as dis-
tinct from a second abundant class of centromeric alphoid
sequences lacking the CENPB box motif)44 and that the
presence of such satellite sequences appears to be essential
for de novo human artiﬁcial chromosome formation,45–48
it is tempting to speculate a role for CENPB at centromeres
in which the protein, although nonessential, signiﬁcantly
enhances the recruitment of CENPA to centromeric regions.
Such an observation would also explain why neocentro-
meres are merely a transient structure in evolution, eventu-
ally incorporating satelliteDNA inorder to facilitate optimal
binding of kinetochore proteins (see Centromere Reposi-
tioning, Karyotype Evolution, and Speciation, below).
Centromere Proteins CENPC1 and CENPH
Two other functionally essential innerkinetochore pro-
teins, CENPC1 [MIM 117141] and CENPH [MIM
605607], have also been mapped by ChIP-on-chip on mul-
tiple neocentromeres. Both proteins are known to interact
with CENPA,49 and as a result, the two proteins would berican Journal of Human Genetics 82, 261–282, February 2008 269
expected to occupy overlapping locations with CENPA on
neocentromeres. Indeed, colocalization between CENPC1
and CENPA in ChIP-on-chip studies has been now shown
for three neocentromeres,34,36 and, between CENPH and
CENPA, on two neocentromeres.36 On one neocentromere
there was only partial overlap of the protein binding do-
mains (with CENPC1 and CENPH occupying a subset of
the CENPA domain)36 (Figure 4A). However, the authors
suggested that this result might merely reﬂect less efﬁcient
ChIP antibodies, and this is perhaps the more likely expla-
nation, considering that precise colocalization of CENPA,
CENPC1 and CENPH has been shown with a high-resolu-
tion PCR DNA array at the BBB neocentromere.36
Interestingly, no colocalization was seen between
CENPA and CENPH on the mardel(10) neocentromere—
CENPH was found to be present in a large, 900 kb domain
over 1 Mb distant from the CENPA domain50 (Figure 4B).
The implications of this last result are unclear, but it might
imply a higher-order chromatin folding at this particular
neocentromere—which incidentally was the largest of
the CENPA- or CENPH-mapped neocentromeres—bring-
ing the two separate regions into closer proximity to
enable protein-protein interactions.
The Chromosomal Scaffold
The presence of scaffold or matrix proteins at the cores of
condensed, mitotic chromosomes has long been demon-
strated.51–56 At alphoid centromeres, the frequency of sites
of scaffold attachment increases dramatically,57 suggesting
a tighter compaction of centromeric chromatin. The same
observation has also been shown for two neocentro-
meres,50,58 and the lack of repetitive DNA at neocentro-
meres has allowed the extent of the enhanced scaffold/
matrix attachment region (S/MAR) to be deﬁned. In both
cases, the enhanced S/MAR domain was found to be
much larger than the associated CENPA-binding domain,
covering an expanse of 3.2 Mb for the mardel(10) neocen-
tromere and 2.0 Mb for the invdup(20) neocentromere
(Figure 4B). Although it is unknown whether this domain
represents the physical boundaries of the centromere, it
seems logical to suggest that the enhanced S/MAR domain
deﬁnes the primary constriction considering the clear
change in the physical structure of chromatin at the cen-
tromere.
Of interest, the size of the CENPA-binding domain at
these neocentromeres does not appear to be proportional
to the size of the mapped S/MAR domain. In the case of
the mardel(10) neocentromere, CENPA occupied only
one-tenth of the region of increased scaffold attachment,
whereas at the invdup(20) neocentromere CENPA occu-
pied almost one-quarter of the enhanced S/MAR domain
(Figure 4B).
In both cases, numerous genes were present within the
boundaries of the enhanced scaffold domain, and some
of these have been shown to be transcriptionally active
(see Transcriptional Competence within Neocentromeres,
below).270 The American Journal of Human Genetics 82, 261–282, FebruaryHeterochromatin Protein HP1a
The organizational distribution of the heterochromatin
protein marker HP1a [MIM 604478] has also been studied
on a single neocentromere, themardel(10). Curiously, con-
sidering the strong requirement of heterochromatin for
sister chromatid cohesion at the centromeres of ﬁssion
yeast59,60 and vertebrates,61 the protein showed only slight
enrichment at the neocentromere compared to the pro-
genitor chromosome 10, at a single BAC position 800 kb
distant from the CENPA domain50 (Figure 4B). Although
this region represents a relatively small domain of hetero-
chromatin, it is important to note that the chromatin
immunoprecipitation study was a comparative one, only
measuring the levels of enrichment of the protein. Thus,
it is possible that an extant domain of heterochromatin al-
ready existed at the normal 10q25.3 region, which has
merely been augmented after neocentromere formation.
Transcriptional Competence within Neocentromeres
One of the more fascinating features of neocentromeres is
their location within euchromatic, protein-encoding re-
gions of the genome. This is particularly evident in the
case of the mardel(10) neocentromere, which has a long
gene transcript spanning the entire length of the CENPA-
associated domain (Figure 4). In addition, three other
neocentromeres similarly have known protein-coding
genes within their mapped CENPA-binding domains (Fig-
ure 4A)—indicating that of the sevenmapped innerkineto-
chore plates, the majority contain protein-coding genes.
Whether such euchromatic genes could be expressed
within the boundaries of the kinetochore chromatin has
been a question of considerable interest. The CENPA N-
terminal tail lacks a lysine amino acid at residue 4, prevent-
ing the methylation marks that denote euchromatin and
active genes, and consequently it might be thought that
centromeric chromatin was silent by default. It has also
been shown that CENPA forms a tighter nucleosome struc-
ture62,63 than thehistoneH3-containing alternative,which
might also form a barrier to transcription.
Through comparison of the expression levels of known
protein-coding genes within the mardel(10) neocentro-
mere domain to the same genes on the progenitor chromo-
some 10 from which the neocentric marker chromosome
had formed, investigation of this problem has been possi-
ble. Surprisingly, ATRNL1, the gene that spans the CENPA-
associated domain on the mardel(10) neocentromere, was
found to be actively expressed, and the formation of the
mardel(10) neocentromere at 10q25 did not signiﬁcantly
change the expression levels of this gene.50 Most recently,
this phenomenon of active transcription through a region
of CENPA-containing chromatin has also been demon-
strated in alpha-satellite-containing human artiﬁcial
chromosomes, where the CENPA-containing domain was
shown to not be restricted to the alpha-satellite repeats
but to have spread over the active selective marker
gene64 adjacent to these repeats. Transcriptional compe-
tence of centromeric chromatin has also been shown for2008
two rice centromeres65,66 (see Centromere Repositioning,
Karyotype Evolution, and Speciation, below). From these
results, it appears that CENPA-containing chromatin repre-
sents no barrier to gene transcription.
Within the enriched S/MAR domain of the mardel(10)
neocentromere, there are eight other actively expressed
genes that were similarly unaffected by the formation of
a neocentromere50 (Figure 4). Indeed, the only differences
in gene expression detected after neocentromere forma-
tion was the activation of two protein-coding genes on ei-
ther end of the S/MAR domain,67 where in both instances
the genes were only expressed after neocentromere forma-
tion (Figure 4). These genes corresponded with regions of
hypomethylation at the mardel(10) neocentromere, and
their activation might have been induced as a byproduct
of the epigenetic remodeling that accompanies neocentro-
merization (see Epigenetic Mechanisms of Neocentromere
Formation, below).
Thus, despite the increased scaffold attachment sites
and a corresponding tighter packing of chromatin, gene
transcription can continue regardless within the primary
constriction and is occasionally even promoted. All the ev-
idence therefore points to the centromeric structure being
largely irrelevant to gene transcription and again raises the
question as to the purpose of satellite repeats—which have
been traditionally linked to genetic silencing—at the eu-
karyotic centromere (see further discussion in Centromere
Repositioning,KaryotypeEvolution,andSpeciation,below).
Epigenetic Mechanisms of Neocentromere Formation
Neocentromerization
Although much is now known about the structural and
functional characteristics of neocentromeres, compara-
tively little is known about how they actually form. Cur-
rently, there are no reports of neocentromeres forming
experimentally in human cell lines, and the little informa-
tion that we have stems from studies undertaken in ﬂies
and plants.
The ﬁrst example of neocentromerization occurring ex-
perimentally was from work undertaken in Drosophila, in-
vestigating the germline transmission of fragments of non-
centromeric DNA after radiation damage.68,69 In an initial
study, a small (<300 kb) subtelomeric fragment of a rear-
ranged Drosophila X minichromosome (g238) was shown
to spontaneously form a neocentromere after release by ra-
diation.68 Signiﬁcantly, the rearrangements within the
g238 minichromosome had placed this subtelomeric frag-
ment very close to the repetitive DNA-based normal cen-
tromere of the chromosome. In contrast, when the same
subtelomeric fragment was released from a normal X chro-
mosome, where it is separated from the active centromere
by 40 Mb of DNA, no neocentromere formation was de-
tected.68 A follow-up study released the same subtelomeric
fragment from various sites within the Drosophila genome
and found that a neocentromere was only formed when
the subtelomeric DNA was located within 20 kb of an ac-
tive centromere.69 Such results demonstrated that it wasThe Amea close association to a normal centromere in the g238
minichromosome that was responsible for conferring neo-
centromerization potential on the fragment. These studies
thus suggested that neocentromere formation—in ﬂies, at
least—is reliant upon close-proximity spreading of a cen-
tromeric signal from an active centromere. It should be
noted, however, that these studies were based upon the
neocentromere-forming capacity of a single, short length
of subtelomeric DNA. It is possible that other regions of
the Drosophila genome might be more predisposed to neo-
centromere formation without requiring proximity to an
active centromere.
A second report of neocentromerization has come from
plant chromosomes, and it also describes neocentromeres
forming close to the site of active centromeres.70 This study
used a gametocidal system in wheat to induce structural
changes in added barley chromosomes. Two fragments of
barley chromosome 7 were recovered that lacked the origi-
nal primary constriction and any form of centromeric re-
peats. Both chromosome derivatives were shown to form
telocentric neocentromeres at the pericentric breakpoint
from the original chromosome, suggesting that close-prox-
imity spreading of a centromeric signal from the original
chromosome was the cause of neocentromere formation.70
Despite the above studies, the potential of centromeric
spreading to generate a neocentromere cannot account
for the neocentromere cases reported in humans, where
there is no record of neocentromeres forming near ac-
tive centromeres. Considering the chromosomal rear-
rangements known to result in neocentromere formation,
though, this is not entirely surprising. Neocentric inverted
duplications generally occur far from the centromere on
the distal ends of chromosome arms; balanced chromo-
somal rearrangements contain one fragment with the cen-
tromere and much of the surrounding pericentric DNA.
Thus, although it might be possible for the centromeric sig-
nal to spread in humans just as in ﬂies, this will rarely, if
ever, be seen in vivo. Nevertheless, it is worth noting the
balanced neocentromere rearrangement on chromosome
3 described by 14 where the break points for the rearrange-
ment were within 2 Mb either side of the original alphoid
centromere.14,71 Even in this scenario, no spreading of the
centromeric signal was observed: The neocentromere was
formed at 3q26.1, more than 70 Mb distant from the break
point, rather than in a region close to the original alphoid
centromere.
If the centromere signals do not possess the capability to
spread in humans, at least through considerable distances,
how then are neocentromeres formed? One possibility is
that aberrant incorporation of CENPA at ectopic sites
within the genome during DNA replication might lead to
the formation of a new centromere at mitosis. It is known
that overexpression of CENPA in human and ﬂy cell lines
leads to misincorporation of the protein within the chro-
mosome arms.27,72 There has also been the suggestion
that CENPA misincorporation is common and that subse-
quent protease digestion is required for the removal ofrican Journal of Human Genetics 82, 261–282, February 2008 271
the protein from the chromosome arms during the normal
cell cycle.73,74 Could neocentromerisation, therefore, sim-
ply occur via small pockets of CENPA retained on acentric
fragments? The only evidence that this might be possible
stems from a study in Drosophila, where overexpression
of the Drosophila CENPA ortholog CID was shown to occa-
sionally give rise to regions with ectopic kinetochore activ-
ity, which were able to successfully bind microtubules at
mitosis.27 However, a similar study in humans reported
no such kinetochore formation72 despite observing a high
degree of CENPA incorporation within the chromosome
arms. It seems likely, therefore, that overexpression of
the protein might need to be inordinately high to drive
the formation of ectopic kinetochores in humans, at least,
and that this is unlikely to be a main mechanism of neo-
centromerization (although it might well play a role in
cancer formation—see Cancer, above).
Related to this theory is the idea that CENPA is incorpo-
rated in potential neocentromeric sites at high efﬁciency
but is rapidly removed on chromosomes that already pos-
sess a centromere by factors acting in cis.75 In this hypoth-
esis, each acentric fragment has a strong potential to form
a neocentromere at multiple locations, and each active
centromere plays a role in silencing alternative centro-
meres. Removal of the controlling centromere—by a chro-
mosome rearrangement, break, or epigenetic silencing—
would thus allow one of these alternative regions to form
a neocentromere. In humans, there is some evidence in
support of the idea of centromere silencing in cis: Al-
though functional dicentric X chromosomes with two
pairs of active kinetochores can form when the distance
between the two centromeres is small, once this distance
becomes greater than 12 Mb, two active centromeres are
never observed.76 However, this phenomenon might sim-
ply result from the instability and loss of chromosomes
with a large degree of separation between the two active
centromeres—thereby imposing a positive selection for
chromosomes that have deactivated one of the centro-
meres through various loss-of-function mechanisms—
rather than from the involvement of cis-acting silencing
factors. Furthermore, studies in Drosophila have demon-
strated that a satellite-rich region in a chromosome can
bind centromere proteins and occasionally form an active
centromere, even in the presence of the wild-type active
centromere77—an event that suggests a lack of centromeric
silencing in cis, or at least that certain regions can escape
silencing. (This particularly unusual DNA region, termed
bwD, comprises an insertion of over one megabase of satel-
lite DNA.78 Although it possesses the ability to form an ac-
tive centromere at high frequency after chromosome
breakage, the bwD region is not euchromatic and has a pe-
culiar afﬁnity for centromere proteins. It thus should not
be confused with neocentromeres, which form at nonrep-
etitive regions of the genome and do not bind centromere
proteins prior to chromosome breakage.)
The above hypotheses imply that a protokinetochore is
already present at the site of neocentromere formation be-272 The American Journal of Human Genetics 82, 261–282, Februaryfore breakage of the chromosome (or silencing of the initial
centromere) occurs. An alternative possibility is that the
neocentromere signals are acquired after chromosome
breakage or rearrangement, via aberrant association of
the acentric fragment with centromeric DNA during
CENPA loading.69 Considering that loading of CENPA oc-
curs immediately after cell division and before DNA repli-
cation,79,80 this would imply that neocentromerization
would occur only after the cell has progressed through
one round of division with an acentric fragment.
Perhaps most intriguing of all is the suggestion that
chromosome rearrangements might be responsible for
inducing neocentromere formation, possibly through
a change in the epigenetic state of the chromatin after
DNA repair.10,81 The evidence for this theory is based
upon the high-resolution FISHmapping of two 15q25 neo-
centromeres on inverted-duplicated marker chromosomes.
Themapping showed a close association (to within 500 kb)
between the site of neocentromere formation and the
duplication and rearrangement boundaries of the marker
chromosomes.10 Indeed, a signiﬁcant proportion of all
known inv dup marker chromosomes have a centromere
at the approximate position of the site of recombination
(see Figure 1B for examples of chromosome 13-derived
neocentromeres), suggesting a link between the two
events. In this respect, the possibility of a small inversion
at the mapped BBB neocentromere (see Organization of
Centromere Proteins, above) is particularly interesting,
and it is tempting to suggest that the inversion and forma-
tion of the neocentromere in this case might be related.
Hotspots of Neocentromere Formation
A clearly recognizable trend from the human clinical cyto-
genetic data is the clustering of sites of neocentromere for-
mation at chromosomal ‘‘hotspots.’’75,82 Certain regions of
chromosomes—for example, 3q, 8p, 13q, and 15q—seem
particularly prone to forming neocentromeres (Figure 1A).
In part, this trend must be ameliorated by the recognition
that these sites cluster in chromosomes that are inverted
duplications and that the survival of individuals with
more distal inverted duplications will be favored (as such
individuals possess a smaller region of partial trisomy or
tetrasomy). It is therefore logical to see a clustering of
neocentromeres around the distal ends of chromosomes,
which might explain the 8p hotspot in particular. Never-
theless, it is clear that neocentromere formation in certain
regions is favored, something that is perhaps best illus-
trated by the neocentromeres found on chromosome 13.
Within the q arm of this chromosome, two clear regions
of neocentromere formation, or hotspots, are present
within the cytogenetic bands 13q21 and 13q32, and the
formation of neocentromeres within these bands does
not appear to be related to the length of the marker chro-
mosome (Figure 1B).
Whether neocentromeres form at precisely the same
location and underlying genomic DNA sequence within
eachhotspot has been an important issue in understanding2008
neocentromerization. If this were indeed the case, it would
suggest a fundamental relationship between DNA se-
quence (or a highly localized chromatin environment)
and neocentromere formation. This question has been the
subject of investigations into the 13q3233 and 13q21 hot-
spots.34 Both studiesmapped the CENPA- or CENPC1-bind-
ing domains of several neocentromeres known to be located
within these hotspots and found that each binding domain
localized to a different region of the same cytogenetic
band.33,34
These still rather limited data by themselves are not nec-
essarily proof against a common sequence basis for the pri-
mary constriction within these hotspots. The combined
neocentromere mapping studies (described in Organiza-
tion of Centromere Proteins, above) suggest that the exact
location of the CENPA domain within the primary con-
striction (as indicated by the S/MAR domain) might be
variable, raising the possibility that the same region of
the chromosome forms a primary constriction each time,
within which the position of the CENPA domain might
change. However, the distance between the 13q neocen-
tromeres investigated in these studies suggests that this
scenario is unlikely. In the case of three 13q32 neocentro-
meres, the CENPA domains of each centromere were found
to be located within a stretch of more than 6 Mb of DNA,33
with two domains separated by over 5 Mb; similarly, the
two 13q21 neocentromeres were separated by over 3 Mb
of DNA. These distances are greater than the size of either
previously mapped neocentric constriction50,58 and sug-
gest that the neocentromeres studied have indeed formed
at different locations within the cytogenetic bands.
If the exact chromosomal location is not a contributing
factor, could there be more general characteristics of
neocentromere hotspots that make them conducive to
neocentromere formation? One possibility is that neocen-
tromerization is favored in gene-poor regions of the ge-
nome.34 It is logical to assume that such regions might
be more conducive to subsequent incorporation of alpha-
satellite DNA and pericentric heterochromatin, and there
are indeed some regions of the genome that have a low
gene density and appear to be favored for neocentromere
formation (e.g., 9p23). However, there are also apparent
hotspots in relatively gene-rich cytogenetic bands (e.g.,
13q32), implying that there is no clear consensus as to
where neocentromeres are formed. Similarly, the observa-
tion that the CENPA domains of the 13q32 neocentro-
meres observed by Alonso et al.33 were found between ac-
tive genes appears not to be a general trend, judging by the
presence of active genes within the CENPA domains of
three other neocentromeres (see Organization of Centro-
mere Proteins, above). Finally, the mapped S/MAR do-
mains [on the mardel(10) and invdup(20) neocentro-
meres] occupy regions ﬁlled with known protein-coding
genes, at least some of which are known to be actively ex-
pressed50 (Figure 4B). From the above evidence, therefore,
it seems unlikely that gene density is a deciding factor in
the positioning of neocentromeres (although it might re-The Amelate to the propensity of a neocentromere to become sub-
sequently ﬁxed in the population—see Centromere Repo-
sitioning, Karyotype Evolution, and Speciation, below).
An alternative explanation for the existence of neocen-
tromere hotspots relates to the possible link between
genome rearrangement and neocentromere formation,
discussed above.10,81 This theory suggests that regions of
the genome with a high content of duplications are predis-
posed to rearrangements, which then lead to neocentro-
mere formation through epigenetic changes in the chro-
matin after DNA repair. Such a hypothesis would also
explain the link between several neocentromere hotspots
and the locations of ancestral centromeres (which have
a high number of duplicons).10 There has not yet been
a comprehensive analysis of the ‘‘older’’ duplicons within
the genome that appear to be associated with this phe-
nomenon,34 so assessment of whether this theory can ex-
plain all known hotspots is currently impossible. However,
there is a good correlation between duplicons and sites of
neocentromere formation seen at neocentromere hotspots
from 15q,10 13q21,34 and 3q26,71 suggesting that such
a connection between duplications and neocentromeri-
zation might be a distinct possibility.
One ﬁnal point of interest regarding neocentromere hot-
spots is the accuracy of conventional cytogenetic mapping
of the primary constriction. Two of the supposed 13q32
neocentromeres mentioned above were shown through
chromatin immunoprecipitation and genomic array analy-
sis to have CENPA domains within the next cytogenetic
band, 13q33,33 suggesting that some previously reported
band locations of neocentric constrictions might be inac-
curate. In other words, the clustering of neocentromeres
at particular cytogenetic bands might not be as extensive
as the literature would suggest.
DNA Sequence Similarities
Considering the homology of repetitive satellite sequences
at the normal centromeres of an organism, numerous stud-
ies have sought to ﬁnd a correlation in the DNA sequences
of neocentromeres, in particular in the sequence of known
CENPA-binding domains.6,32–35 Currently, most analyses
of these domains have failed to ﬁnd signiﬁcant deviations
from the genome average, in terms of various centromere
motifs or repetitive elements. However, one observable
trend is the AT base-pair content of the CENPA binding re-
gions: This has been shown to be consistently higher than
normal in all seven neocentromeres observed, ranging
from 59.9% content to 66.1%, with the genome average
being 59%.6,32–34 Whether this is a major factor for deter-
mining the site of neocentromere formation is less clear,
though. The three neocentromeres investigated by Alonso
et al.33 were located within 6 Mb of each other, yet the AT
content of their CENPA-binding domains varied between
59.9% and 65.0%. If AT content was indeed a deciding
factor in determining the site of neocentromerization, it
is surprising that all three neocentromeres did not form
within the region of highest AT content. Similarly,rican Journal of Human Genetics 82, 261–282, February 2008 273
a comprehensive analysis of the AT content of the seven
mapped neocentromeres and the surrounding DNA sug-
gested that there was little correlation between regions of
extremely high AT content and neocentromere forma-
tion.36 Nevertheless, a threshold AT content requirement
of at least the genome average is a possibility that cannot
be discounted.
The only other clear signiﬁcant difference in DNA con-
tent within a neocentromere was reported in the high-res-
olution CENPA mapping study of Chueh et al.35 Although
no difference was noted over the entire CENPA binding do-
main of the mardel(10) neocentromere, when analyzing
the separate peaks of CENPA binding within this domain
a signiﬁcant increase was observed in the number of retro-
transposable L1 LINE elements (LRE1 [MIM 151626]) com-
pared to the surrounding histone H3-containing regions.
Analysis of the BBB neocentromere, the other neocentro-
mere mapped at PCR-fragment resolution, also showed
a higher frequency of L1 elements (and MaLR LTR ele-
ments) within the peaks of CENPA binding compared to
the intervening DNA,36 and a 70bp motif associated with
young L1 elements was found to be the only common fea-
ture shared between the DNA sequence of the seven map-
ped neocentromere domains.36 An association between L1
content and neocentromere formation is therefore a dis-
tinct possibility, although the exact basis of this associa-
tion is at this stage unclear.
Epigenetic Maintenance
Once a new centromere has been formed, there remains
a further interesting question of how the position and
boundaries of the centromere is subsequently maintained.
Without evidence of DNA sequence speciﬁcity at neocen-
tromeres, it appears that epigenetic marks are the means
through which this is achieved. CpG island methylation
is an obvious candidate for this process, and a comprehen-
sive study of CpG methylation at the mardel(10) neocen-
tromere was recently carried out by Wong et al.67 This
study looked not only at CpG islands (stretches of DNA
longer than 200 bp enriched for CpG dinucleotides) but
also at smaller regions (‘‘islets’’) enriched for CpG residues.
The ﬁndings of this study were striking: Although islets
and islands within the extended S/MAR region were gener-
ally hypermethylated at the neocentromere when com-
pared to the progenitor chromosome 10, at the boundaries
of the CENPH, HP1a, and enriched S/MAR domains, there
was clear hypomethylation of islands or islets.
Such results could, of course, be coincidental—only
a similar correlation seen at the boundary elements of
other neocentromeres would conﬁrm this uncategorically.
Nevertheless, the results are intriguing, especially when
seen in the light of a trend of hypermethylation of CpG
residues located elsewhere within the neocentromere do-
main. Furthermore, the study showed that the hypome-
thylated state of these regions was preserved even after
chromosomal transfer from a Chinese Hamster Ovary
background to two different mouse cell lines—suggesting274 The American Journal of Human Genetics 82, 261–282, Februarythat the maintenance of such epigenetic marks is strong.67
However, it is currently unknown whether such marks ac-
tively demarcate the boundaries of neocentromeres or are
simply created in response to the changes in chromatin
caused by the formation of a neocentromere.
An alternative and perhaps additional means of epige-
netic regulation of neocentromeres lies in themodiﬁcation
of histones through acetylation. The role of histone acety-
lation at the centromere appears to be complex. Histone
hyperacetylation through trichostatin A (TSA) treatment
has been shown to induce kinetochore formation in inte-
grated human engineered chromosomes (HECs)83 and re-
store the loading of CENPA at centromeric regions when
histone chaperone proteins normally associated with this
loading are knocked down.84 In this context, the response
of the CENPA and scaffold/matrix binding domains to tri-
chostatin A (TSA) treatment at the mardel(10) neocentro-
mere was surprising.85,86 Hyperacetylation was shown to
cause a striking change in both domains: The CENPA do-
main was found to shift in position by 320 kb in response
to histone hyperacetylation,85 yet at the same time, the
S/MAR domain was observed to shrink to less than half
of its original size.86 Both studies thus suggested a link be-
tween histone acetylation and the position of the neocen-
tromere.
Notably, however, the shift in position of the CENPA do-
main observed in response to TSA treatment was found to
be reversible following removal of the drug85—suggesting
that other epigenetic marks such as CpG methylation
discussed above might play a role in the maintenance of
neocentromeres. Further studies are needed to investigate
whether TSA treatment affects the hypomethylated re-
gions found at this neocentromere and whether induced
changes to the DNAmethylation environment can perturb
the formation of the S/MAR domain.
A further interesting observation regarding the epige-
netics of neocentromeres stems from engineered neocen-
tric minichromosomes (NC-MiCs). Several NC-MiCs have
been created by telomere-associated chromosome trunca-
tion of the mardel(10) marker chromosome, the smallest
of which is approximately 650 kb in size.87,88 This circular
minichromosome, NC-MiC5, is thus many times smaller
than the native S/MAR domain on the original neocentro-
mere, and yet the chromosome is still capable of forming
a fully functional neocentromere in cell culture. Such re-
sults would seem to indicate a pliability of centromeric
chromatin that can rapidly adapt to structural changes—
a hypothesis for which we have preliminary data in sup-
port (L.H.W. and K.H.A.C., unpublished data).
Centromere Repositioning, Karyotype Evolution,
and Speciation
From a clinical viewpoint, neocentromere formation
provides little evolutionary advantage. Although the
formation of a neocentromere rescues the carrier from
embryonic lethality, the chromosomal rearrangements
associated with neocentromere formation are generally2008
deleterious, resulting in either partial trisomy or tetrasomy
or in a ring chromosome that is subject to aneuploidy. The
ability to form a neocentromere might also aid the path-
way to cancer (see Cancer, above). Why, then, does the
process of neocentromere formation occur at all, and
with reasonable frequency?
The answer to this intriguing question might lie with
a rare type of neocentromere reported in the clinical
literature. These neocentromeres are formed on an intact
chromosome with the preexisting, repetitive-DNA-based
centromere still present, but inactivated. In essence, the
active centromere on these pseudodicentric chromosomes
has been repositioned. Such neocentromeres are uncom-
mon, with only ﬁve cases reported in the literature.71,89–92
However, considering that no obvious clinical defect is as-
sociated with the individuals carrying these repositioned
centromeres, thismode of neocentromere formationmight
be more common than the statistics indicate.
Three examples of this pseudodicentric neocentric phe-
nomenon were neocentromeres that formed in the hetero-
chromatic long arm of the Y chromosome.89–91 Although
one example was present with a high degree of mosaicism
and instability,90 the other two examples were stably trans-
mitted through at least three generations of males, with
the alpha-satellite DNA of the preexisting centromere still
present on the chromosome arms, but failing to form
a constriction. Quantitative FISH analysis of the alpha-sat-
ellite remaining at one inactive centromere suggested that
there might have been a partial deletion of the alphoid
DNA, although the amount was only slightly outside the
range of normal variation seen for the Y centromere in
the population.91
Although the heterochromatic long arm of the Y chro-
mosome might be particularly predisposed to neocentro-
mere formation, a further two cases of centromere repo-
sitioning have involved the autosomes.71,92 In one
example, on chromosome 3, the neocentromere was re-
corded to have been transmitted through one generation,
having formed de novo in the father.71 However, with
the other example, on chromosome 4, the original progen-
itor of the chromosome could not be determined, with the
chromosome stably inherited through at least two genera-
tions without any alpha-satellite being present at the
primary constriction.92 The levels of alpha-satellite DNA
remaining at the old centromere in this last case were
quantitated via FISH, but without the original progenitor
chromosome 4 available for study, it was unclear whether
the amount of satellite DNA had been reduced. Although
the amount of satellite DNA was found to be low for chro-
mosome 4, the quantity (approximately 1.3 Mb) was
within the range of variation seen within the population.92
The fact that there might have been a reduction in the
amount of satellite DNA at the old centromere in two cases
raises an interesting possibility: Could neocentromere for-
mation in these examples have been induced by the weak-
ening or deactivation of the old centromere by partial de-
letion? However, even if all cases had involved deletionsThe Ameof alpha-satellite at the old centromeres, it would not nec-
essarily mean that such deletions were the cause of neo-
centromere formation. In each instance where the amount
of alpha-satellite remaining on the centromere was quanti-
tated, the original progenitor of the neocentromere could
not be traced, meaning that the neocentromere could
potentially be many generations old.91,92 In such cases,
a gradual mutation and loss of the alpha-satellite DNA at
the inactive centromere would be expected.
These pseudodicentric neocentric cases are especially in-
teresting, considering the well-documented process of cen-
tromere repositioning seen in vertebrates. Comparative
studies of chromosomes in primates, other mammals,
and birds have demonstrated that the positioning of
centromeres changes over the course of evolution, by
means unrelated to the surrounding pericentric DNA
markers.34,71,81,93–96 These observations were ﬁrst demon-
strated for the evolution of chromosome IX in primates93
but have since been reproduced through the observations
of other chromosomes in primates,81 birds,96 and other
mammals.34,97 In all such cases, the order of the DNA
markers surrounding the new centromeric location had re-
mained unchanged, and the most parsimonious series of
chromosomal rearrangements suggested that one centro-
mere had been deactivated and a new centromere formed
de novo at a new location.
Could such repositioning come about through a neocen-
tric intermediate? Although the possibility cannot be ex-
cluded that repositioned centromeres are formed through
the spontaneous, ectopic incorporation of centromeric sat-
ellite DNA, the examples of pseudodicentric neocentric
chromosomes presented above strongly suggest that neo-
centromeres are indeed the means of centromere reposi-
tioning. In each of these cases, the neocentromere in ques-
tion was stably transmitted through multiple generations,
with the old, alphoid centromere remaining inactivated.
Furthermore, there seems to be a relationship between re-
gions known to form neocentromeres on human chromo-
somes and the sites of evolutionary centromere reposition-
ing events in other organisms. On chromosomes 15, 3, and
13, centromere-repositioning events have occurred several
times in regions known to favor neocentromere for-
mation.10,34,71
Of course, such repositioned centromeres do not remain
devoid of repetitive satellite DNA but must acquire it dur-
ing subsequent evolution. Most intriguing in this respect
are the recent studies of two rice centromeres.65,66 Al-
though most rice chromosomes contain typical centro-
meres demarcated by long stretches of satellite repeats
embedded within heterochromatin, the centromere on
chromosome 8 (Cen8) is unusual, containing an extremely
low quantity (40 kb) of satellite repeats.65 Mapping of the
binding domain of CENH3 (the rice paralogue of CENPA)
by ChIP and PCR demonstrated that although this block
of satellite DNA lay within the centromeric chromatin,
most of the 750 kb CENH3 domain was occupied by
actively transcribed genes65 and was thus very similar torican Journal of Human Genetics 82, 261–282, February 2008 275
mapped human neocentromeres (see Transcriptional
Competence within Neocentromeres, above). Cen8 might
thus represent the next step in the centromere reposition-
ing process: an example of a neocentromere that has be-
come ﬁxed within the species and is beginning to slowly
incorporate satellite repeat sequences. A second mapped
rice centromere, Cen3, possibly represents a step further
in this evolutionary process. On this centromere, the satel-
lite DNA occupied a much larger block of 450 kb, but the
remainder of the 1.8 Mb region of CENH3 binding was
again occupied by actively transcribed genes.66
Interestingly, it appears that the satellite repeat se-
quences do not gradually integrate throughout the active
genes of a neocentromere, but rather expand outwards
from a single location. In the case of a centromere-reposi-
tioning event within chromosome 6 in Old World mon-
keys, large amounts of satellite and repetitive sequences
associated with the new centromere appear to have been
introduced at the new centromere site without any change
to the surrounding sequences at a BAC resolution level.95
The incorporation thus appears to be more in the nature
of an initial insertion followed by expansion (through
mechanisms such as unequal crossing over) rather than
a gradual accumulation of satellite DNA over multiple re-
gions within the neocentromere. If this is indeed the
case, then the centromere must be capable of a gradual
shift, from the euchromatic DNA of the initial neocentro-
mere to the introduced satellite sequences, without overtly
compromising the genetic content of the region.
There is some evidence, though, that the two gene-con-
taining rice centromeres described abovemight be unusual
cases in the process of centromere repositioning. Although
the gene-density at both rice centromeres is lower than the
surrounding regions, recent studies of chromosome 13 and
the Macaque genome have suggested that centromere-re-
positioning events generally occur in ‘‘gene deserts’’—large
regions of the genome that are completely devoid of
genes.34,81 Although neocentromerization clearly does
not affect gene expression per se (see Transcriptional Com-
petence within Neocentromeres, above), the eventual in-
corporation of heterochromatin at mature centromeres
(see below) might ultimately inﬂuence the expression of
genes within the centromeric region. It has thus been
hypothesized that a lack of genes within sites of neocentro-
mere formation on pseudodicentric neocentric chromo-
somes might be an important factor in the determination
of whether the neocentromere becomes subsequently
ﬁxed in the population and incorporates satellite
sequences.81
Precisely why the subsequent incorporation of satellite
sequences at repositioned centromere sites occurs, how-
ever, remains a mystery. Clearly, there must be an evolu-
tionary advantage in having repetitive DNA at centro-
meres, because neocentromeres are not known to have
become ﬁxed in the population of any organism studied
to date without the incorporation of repetitive satellite
DNA. One possibility is that repetitive satellite DNA might276 The American Journal of Human Genetics 82, 261–282, Februaryhelp to increase the loading of constitutive centromere
proteins such as CENPA at centromeres. This theory has
been supported by studies of the levels of CENPA present
at centromeres,whichhas shown signiﬁcantly less amounts
of the protein to be present at neocentromeres (Irvine
et al.,43 and see Organization of Centromere Proteins,
above.) If this was the case, the presence of satellite DNA
could be rapidly selected for via thephenomenonofmeiotic
drive.98
An alternate possibility for the incorporation of satellite
DNA at neocentromeres is that repetitive DNA, being de-
void of active genes, helps to promote a heterochromatic
environment more favorable for sister chromatid
cohesion. Centromeric heterochromatin is known to be
necessary for sister-chromatid cohesion in yeast59,60 and
vertebrates,61 and an increase in the amount of hetero-
chromatin could allow the centric region to better with-
stand microtubule tension and aid the stability of the
chromosome during mitosis and meiosis. Considering the
generally high mitotic stability of balanced neocentromere
marker chromosomes, this possibility might be regarded as
less likely. However, signiﬁcantly greater sister-chromatid
separation after mechanical stress has been documented
for at least one neocentromere (the pseudodicentric neo-
centric chromosome 4 mentioned above) indicating a pos-
sible reduction in chromatid cohesion,92 and this might be
a contributing factor to the eventual ﬁxation of satellite
sequences.
Naturally, repositioning of the centromere on a chromo-
some provides an effective mechanism of reproductive iso-
lation and thus evolutionary speciation. If neocentromere
formation was indeed the cause of this process—some-
thing which from the above discussion appears highly
likely—this would provide a simple explanation as to
why mechanisms exist to drive neocentromere formation.Conclusions
Neocentromeres are thus a fascinating example of epige-
netic change within the genome. Although most com-
monly observed on rearranged fragments of chromosomes
and occasionally in cancer cells, they appear to possess
a broader role in providing a means of directing centro-
mere repositioning and thereby speciation. By nature of
their formation within nonrepetitive DNA sequences, neo-
centromeres have provided many insights into the pro-
cesses of centromere formation and maintenance and
into the structure and function of the centromere itself.
Many questions remain unanswered, however, and future
research is likely to focus on themechanisms of neocentro-
mere formation and its possible role in cancer etiology and
disease development. Of particular interest is the underly-
ing question of centromere and chromosome evolution.
To what extent has neocentromere formation impacted
on speciation? How is the transition between a neo-
centromere and a repetitive-DNA-based centromere2008
orchestrated? The next 5 years of neocentromere research
are likely to see an integration with the broader centromere
ﬁeld, with a recognition that neocentromeres and repeti-
tive-DNA-based centromeres are intimately related. Ulti-
mately, a deeper understanding of both forms of centro-
mere is important in the deciphering of the structure and
function of the primary constriction.Acknowledgments
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